Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 台中附設醫院 > 期刊論文 > Item 310903500/30480

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/30480

题名:	Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer
作者:	Hsu, NY;Ho, HC;Chow, KC;Lin, TY;Shih, CS;Wang, LS;Tsai, CM
贡献者:	附設醫院醫研部;China Med Coll Hosp, Dept Med Res, Taichung 404, Taiwan;China Med Coll Hosp, Div Chest Surg, Dept Surg, Taichung 404, Taiwan;China Med Coll Hosp, Dept Pathol, Taichung 404, Taiwan;China Med Coll, Sch Med, Taichung 404, Taiwan;Vet Gen Hosp, Dept Chest, Sect Thorac Oncol, Taipei 112, Taiwan
日期:	2001
上传时间:	2010-09-24 14:56:11 (UTC+8)
出版者:	AMER ASSOC CANCER RESEARCH
摘要:	Epstein-Barr virus (EBV) has been linked to carcinomas of several body sites, especially of the nasopharynx, salivary gland, lung, and stomach. We present five cases of lymphoepithelioma-like cholangiocarcinoma, including one that had been previously reported. Two patients were men and three were women. Their ages ranged from 42 to 66 years. Histologically, all five tumors were composed of variable proportions of undifferentiated epithelial cells and glandular components in a lymphocyte-rich stroma. EBV was detected in all five tumors by in situ hybridization for EBER-1 in both lymphoepithelioma-like carcinoma (LELC) and glandular parts, but not in 36 cases of cholangiocarcinoma without the LELC component. Taken together, these observations indicate that lymphoepithelioma-like cholangiocarcinoma, is strongly linked to EBV. The LELC type of cholangiocarcinoma, like LELC of other body sites, may be more common in areas with endemic EBV infection.
關聯:	CANCER RESEARCH 61(6):2727-2731
显示于类别:	[台中附設醫院] 期刊論文

文件中的档案:

没有与此文件相关的档案.

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....